A global diabetes care leader used AI to reduce insulin treatment dropouts by identifying at-risk patients and delivering personalized support. The AI-powered Early Warning Engine and tailored engagement program led to a 30% drop in patient discontinuation, a 25% increase in adherence, and better health outcomes. The initiative also improved resource efficiency by 20%, showcasing AI’s potential to enable proactive, patient-centered care.
To identify at-risk patients and prevent treatment discontinuation by implementing an AI-powered Early Warning Engine and personalized long-term support program.
The AI-powered approach to predicting and preventing patient dropout proved transformative for the pharmaceutical leader, achieving notable reductions in dropout rates and improving patient health outcomes. By implementing an Early Warning Engine and a personalized support program, the company effectively enhanced medication adherence, optimized resources, and delivered tailored interventions that supported patients throughout their treatment journey. This AI-driven solution not only met immediate goals but also set a strong foundation for scalable, patient-centered care, underscoring AI’s potential to drive impactful, data-driven healthcare improvements